Cargando…

Precision medicine in the treatment stratification of AML patients: challenges and progress

Recent advances in high throughput technologies have led to the generation of vast amounts of clinical data and the development of personalized medicine approaches in acute myeloid leukemia (AML). The ability to treat cancer patients based upon their individual molecular characteristics or drug sens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lohse, Ines, Statz-Geary, Kurt, Brothers, Shaun P., Wahlestedt, Claes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340870/ https://www.ncbi.nlm.nih.gov/pubmed/30701032 http://dx.doi.org/10.18632/oncotarget.26492

Ejemplares similares

Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients
por: Dennison, Jessica L., et al.
Publicado: (2022)

Therapeutic potential of neuropeptide Y (NPY) receptor ligands
por: Brothers, Shaun P, et al.
Publicado: (2010)

Emerging treatment strategies for glioblastoma multiforme
por: Carlsson, Steven K, et al.
Publicado: (2014)

Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma
por: Lohse, Ines, et al.
Publicado: (2018)

Oxytocin and social functioning
por: Jones, Candace, et al.
Publicado: (2017)

Progress and challenges in precision medicine
por: Verma, Mukesh, et al.
Publicado: (2016)

A Novel RNA Transcript with Antiapoptotic Function Is Silenced in Fragile X Syndrome
por: Khalil, Ahmad M., et al.
Publicado: (2008)

A novel strategy for combination of clofarabine and pictilisib is synergistic in gastric cancer
por: Khalafi, Shayan, et al.
Publicado: (2021)

Naturally occurring compounds as pancreatic cancer therapeutics
por: Lohse, Ines, et al.
Publicado: (2018)

mRNA-to-protein translation in hypoxia
por: Chee, Nancy T., et al.
Publicado: (2019)

Achieving Precision Medicine in Allergic Disease: Progress and Challenges
por: Proper, Steven P., et al.
Publicado: (2021)

Safety and pharmacokinetics of a highly bioavailable resveratrol preparation (JOTROL (TM))
por: Kemper, Christopher, et al.
Publicado: (2022)

Toward Molecular Stratification and Precision Medicine in Systemic Sclerosis
por: Noviani, Maria, et al.
Publicado: (2022)

Low-Dose Chidamide Treatment Displays Sex-Specific Differences in the 3xTg-AD Mouse
por: Dennison, Jessica, et al.
Publicado: (2023)

The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models
por: Aziz, Abdul Maruf Asif, et al.
Publicado: (2016)

Precision medicine in inflammatory bowel disease: concept, progress and challenges
por: Borg-Bartolo, Simon P., et al.
Publicado: (2020)

Liquid Profiling for Cancer Patient Stratification in Precision Medicine—Current Status and Challenges for Successful Implementation in Standard Care
por: Haselmann, Verena, et al.
Publicado: (2022)

P412: TRANSCRIPTOMIC CLASSIFICATION, RISK STRATIFICATION AND THERAPY SELECTION IN AML
por: Severens, Jeppe, et al.
Publicado: (2023)

Junctional Epidermolysis Bullosa: Allelic Heterogeneity and Mutation Stratification for Precision Medicine
por: Condrat, Irina, et al.
Publicado: (2019)

Tensions in ethics and policy created by National Precision Medicine Programs
por: Minari, Jusaku, et al.
Publicado: (2018)

BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT
por: Copsel, Sabrina N., et al.
Publicado: (2019)

Personalized medicine in psychiatry: problems and promises
por: Ozomaro, Uzoezi, et al.
Publicado: (2013)

Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research
por: Dennison, Jessica L., et al.
Publicado: (2021)

Inhibition of HDAC3 reverses Alzheimer’s disease-related pathologies in vitro and in the 3xTg-AD mouse model
por: Janczura, Karolina J., et al.
Publicado: (2018)

Early Diagnosis, Early Stratification, and Early Intervention to Deliver Precision Medicine in IBD
por: Noor, Nurulamin M, et al.
Publicado: (2021)

The Challenge of AML in Older Patients
por: Burnett, Alan K
Publicado: (2013)

RNAi Screen Indicates Widespread Biological Function for Human Natural Antisense Transcripts
por: Faghihi, Mohammad Ali, et al.
Publicado: (2010)

HDAC Inhibitors Induce BDNF Expression and Promote Neurite Outgrowth in Human Neural Progenitor Cells-Derived Neurons
por: Bagheri, Amir, et al.
Publicado: (2019)

Natural Antisense Inhibition Results in Transcriptional De-Repression and Gene Upregulation
por: Modarresi, Farzaneh, et al.
Publicado: (2012)

Progress toward Better Treatment of Therapy-Related AML
por: Kotsiafti, Angeliki, et al.
Publicado: (2023)

The Interplay Between the Genetic and Immune Landscapes of AML: Mechanisms and Implications for Risk Stratification and Therapy
por: Mendez, Lourdes M., et al.
Publicado: (2019)

Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine
por: Benfaremo, Devis, et al.
Publicado: (2023)

AML with Myelodysplasia-Related Changes: Development, Challenges, and Treatment Advances
por: Koenig, Kristin L., et al.
Publicado: (2020)

The promise and challenges of precision medicine in dilated cardiomyopathy
por: Mason, Samantha, et al.
Publicado: (2021)

Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance
por: Levin, May, et al.
Publicado: (2021)

Molecular-targeted therapy toward precision medicine for gastrointestinal caner: Current progress and challenges
por: Matsuoka, Tasuku, et al.
Publicado: (2021)

Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illness
por: Seymour, Christopher W., et al.
Publicado: (2017)

Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML
por: Oellerich, Thomas, et al.
Publicado: (2019)

Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification
por: Kansal, Rina
Publicado: (2016)

MediBoost: a Patient Stratification Tool for Interpretable Decision Making in the Era of Precision Medicine
por: Valdes, Gilmer, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m5tk41pilouq96adhbj4dof0v1